+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

ePharmacies - Global Strategic Business Report

  • PDF Icon

    Report

  • 242 Pages
  • November 2024
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 1882091
The global market for ePharmacies was estimated at US$84.7 Billion in 2023 and is projected to reach US$222.8 Billion by 2030, growing at a CAGR of 14.8% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

E-pharmacies, or online pharmacies, have dramatically transformed the pharmaceutical landscape by leveraging the rise of internet technology to deliver medications directly to consumers. This transition to digital platforms offers unprecedented convenience, eliminating the need for physical visits to pharmacies and enabling prescriptions to be processed and delivered through a seamless, contact-free online system. Utilizing e-prescribing systems, doctors can send prescriptions directly to pharmacies, where medications are selected, paid for online, and delivered via mail or courier services. This model not only meets modern health-conscious demands by minimizing physical interactions but also reduces overhead costs for e-pharmacies, allowing them to offer medications at lower prices than traditional brick-and-mortar locations. Additionally, the online model supports privacy and reduces the risk of human error, enhancing patient safety and providing customers with comprehensive medication information, thereby increasing transparency and consumer education.

The growth of e-pharmacies is significantly influenced by their integration with broader health technology systems, such as electronic health records (EHRs) and advanced data analytics. These integrations streamline the prescription to delivery pipeline, enhance operational efficiency, and allow for personalized marketing and efficient inventory management. Consumer trust has also shifted positively towards online transactions, encouraged by robust security measures and encryption technologies that protect sensitive health data. Moreover, the widespread adoption of mobile technology enables consumers to access e-pharmacy services on-the-go, further enhancing convenience. The expansion of telemedicine contributes to this growth, creating a direct link between virtual health consultations and immediate prescription fulfillment via online platforms. Increased health awareness among consumers who are keen on managing their health proactively also fuels the demand for e-pharmacies.

Regulatory support and evolving digital health policies are pivotal in facilitating the growth of e-pharmacies. Regulations allowing electronic prescriptions and the expansion of mail-order services within healthcare plans are critical enablers. Additionally, logistics and distribution innovations, including the potential use of drones for delivery, are set to improve the reliability and speed of pharmaceutical deliveries, supporting the operational model of e-pharmacies. These factors collectively underscore a shift towards more integrated and technologically advanced healthcare solutions, reflecting broader trends towards digitalization in response to changing consumer needs and the ongoing evolution of healthcare practices.

Key Insights:

  • Market Growth: Understand the significant growth trajectory of the Over-The-Counter (OTC) Drugs segment, which is expected to reach US$123.3 Billion by 2030 with a CAGR of a 13.6%. The Prescription Drugs segment is also set to grow at 16.5% CAGR over the analysis period.
  • Regional Analysis: Gain insights into the U.S. market, which was estimated at $29.7 Billion in 2023, and China, forecasted to grow at an impressive 20.2% CAGR to reach $34.0 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

  • Detailed Market Analysis: Access a thorough analysis of the Global ePharmacies Market, covering all major geographic regions and market segments.
  • Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
  • Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global ePharmacies Market.
  • Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

  • How is the Global ePharmacies Market expected to evolve by 2030?
  • What are the main drivers and restraints affecting the market?
  • Which market segments will grow the most over the forecast period?
  • How will market shares for different regions and segments change by 2030?
  • Who are the leading players in the market, and what are their prospects?

Report Features:

  • Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
  • In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
  • Company Profiles: Coverage of major players such as 1mg Technologies Pvt. Ltd., Canada Drugs, DocMorris NV, and more.
  • Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Select Competitors (Total 63 Featured):

  • 1mg Technologies Pvt. Ltd.
  • Canada Drugs
  • DocMorris NV
  • Dr Fox Pharmacy
  • eDrugstore.com
  • Express Scripts Holding Company
  • Giant Eagle, Inc.
  • InternationalDrugMart.com
  • MediSave
  • Netmeds Marketplace Limited
  • OptumRx, Inc.
  • PlanetRx
  • Rowlands Pharmacy
  • The Kroger Company
  • Walgreen Co.,
  • Wal-Mart Stores, Inc.
  • Zur Rose Group AG

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • What’s the Current State of Global Drug Distribution?
  • ePharmacies, an Emerging Link in the Distribution System with the Promise of Closing the Gap in Modern Healthcare
  • As Global Medicine Demand Breaches the Trillion Dollar Mark, ePharmacies Role in Enabling Better Access to Medicines is Poised to Grow Bigger: Global Medicine Spending (In US$ Billion) for the Years 2022, 2024, 2026, 2028 and 2030
  • Economic Frontiers: Trends, Trials & Transformations
  • In a World Torn by Geopolitical Instability & War, Steadfastness of Global GDP Becomes Increasingly Unpredictable Given the Many Direct and Indirect Economic Repercussions: World Economic Growth Projections (Real Gross Domestic Product (GDP), Annual % Change) for the Years 2022 Through 2025
  • All Eyes on Global Inflation, the Main Risk Factor in Global Markets: Global Headline Inflation Rates (In %) for the Years 2019 through 2025
  • With Oil Prices Influencing the Rate of inflation, it Remains the Most Watched Commodity in Global Markets: Global Average Annual Brent Crude Oil Price (In US$ Per Barrel) for Years 2019 through 2025
  • Competition
  • ePharmacies - Global Key Competitors Percentage Market Share in 2024 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • ePharmacies: Overview & Types
  • Influencer/Product/Technology Insights
  • Recent Market Activity
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
  • Advanced Internet Infrastructure & Robust Smartphone Penetration Provide the Launchpad for the Rise of ePharmacies
  • Access to Internet Equals Access to e-Pharmacy Services: Global Internet Users (In Million) for Years 2018 through 2025
  • Smartphones Provide the Gateway to Access e-Pharmacies: Global Smartphones Users (In US$ Million) for Years 2024, 2026, 2028 and 2030
  • Improved Digital Payment Solutions Sustain Growth in e-Pharmacies
  • Enhanced Digital Payment Solutions Propel E-Pharmacy Sales to New Heights: Global Digital Payments Transaction Value (In US$ Trillion) for Years 2024, 2026, 2028, 2030, and 2032
  • Healthcare Challenges of an Aging Population Opens Opportunities for e-Pharmacies
  • E-Pharmacies Revolutionize Healthcare for Aging Populations, Enhancing Accessibility and Reducing Costs: Global Aging Population (Aged 65+ In Million) for Years 2024, 2040, 2050 and 2100
  • Rapid Evolution of Telemedicine Drives Demand Opportunities for e-Pharmacies Services
  • From Virtual Consultations to Doorstep Delivery, Telemedicine-E-Pharmacy Alliance is Poised to Score Big Gains in the Market: Global Telemedicine Market (In US$ Billion) for Years 2024, 2026, 2028, 2030 and 2032
  • New Opportunities Emerge With Seamless Integration of Telepharmacy With e-Pharmacies. Here’s the Story
  • Expanding Mobile Health Creates a Parallel Expansion of Opportunities for e-Pharmacies
  • Advanced mHealth Apps Spearhead the Progress and Integration of e-Pharmacy Apps: Global mHealth Apps Market (In US$ Billion) for Years 2024, 2026, 2028, 2030 and 2032
  • Rise in Chronic Diseases Expands the Addressable Market Opportunity for e-Pharmacies
  • As Disease Burden Rises so Does the Need for Medicines: Global Cost of Chronic Diseases (In US$ Billion) for the Years 2024 and 2030
  • Growing Use of Medicines is a Clear Opportunity for e-Pharmacies to Tap Into: Global Use of Medicines (In Defined Daily Doses (DDD) in Billions) for the Years 2024, 2026 and 2028
  • Rise of AI in ePharmacies, an Exciting Trend to Watch Out For!
  • With Regulators Failing to keep Up, Illegal ePharmacies Cast a Shadow Over the Market
  • As Illegal Pharmacies Eat Away into Legal Markets & Push Up Healthcare Costs by Causing Adverse Health Events, the Need of the Hour is Strict Regulation & Control: Lost Economic Value to U.S. Healthcare Systems Due to Illegal Pharmacies (In US$ Billion) for Years 2020, 2022 and 2024
4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World ePharmacies Market Analysis of Annual Sales in US$ Million for Years 2019 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for ePharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 3: World Historic Review for ePharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2019 through 2022 and % CAGR
  • TABLE 4: World 11-Year Perspective for ePharmacies by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2019, 2024 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Over-The-Counter (OTC) Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Over-The-Counter (OTC) Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2019 through 2022 and % CAGR
  • TABLE 7: World 11-Year Perspective for Over-The-Counter (OTC) Drugs by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2019, 2024 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Prescription Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Prescription Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2019 through 2022 and % CAGR
  • TABLE 10: World 11-Year Perspective for Prescription Drugs by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2019, 2024 & 2030
  • Recent Market Activity
III. MARKET ANALYSIS
UNITED STATES
  • TABLE 11: USA Recent Past, Current & Future Analysis for ePharmacies by Product Type - Over-The-Counter (OTC) Drugs and Prescription Drugs - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 12: USA Historic Review for ePharmacies by Product Type - Over-The-Counter (OTC) Drugs and Prescription Drugs Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2019 through 2022 and % CAGR
  • TABLE 13: USA 11-Year Perspective for ePharmacies by Product Type - Percentage Breakdown of Value Revenues for Over-The-Counter (OTC) Drugs and Prescription Drugs for the Years 2019, 2024 & 2030
CANADA
  • TABLE 14: Canada Recent Past, Current & Future Analysis for ePharmacies by Product Type - Over-The-Counter (OTC) Drugs and Prescription Drugs - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 15: Canada Historic Review for ePharmacies by Product Type - Over-The-Counter (OTC) Drugs and Prescription Drugs Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2019 through 2022 and % CAGR
  • TABLE 16: Canada 11-Year Perspective for ePharmacies by Product Type - Percentage Breakdown of Value Revenues for Over-The-Counter (OTC) Drugs and Prescription Drugs for the Years 2019, 2024 & 2030
JAPAN
  • TABLE 17: Japan Recent Past, Current & Future Analysis for ePharmacies by Product Type - Over-The-Counter (OTC) Drugs and Prescription Drugs - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 18: Japan Historic Review for ePharmacies by Product Type - Over-The-Counter (OTC) Drugs and Prescription Drugs Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2019 through 2022 and % CAGR
  • TABLE 19: Japan 11-Year Perspective for ePharmacies by Product Type - Percentage Breakdown of Value Revenues for Over-The-Counter (OTC) Drugs and Prescription Drugs for the Years 2019, 2024 & 2030
CHINA
  • TABLE 20: China Recent Past, Current & Future Analysis for ePharmacies by Product Type - Over-The-Counter (OTC) Drugs and Prescription Drugs - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 21: China Historic Review for ePharmacies by Product Type - Over-The-Counter (OTC) Drugs and Prescription Drugs Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2019 through 2022 and % CAGR
  • TABLE 22: China 11-Year Perspective for ePharmacies by Product Type - Percentage Breakdown of Value Revenues for Over-The-Counter (OTC) Drugs and Prescription Drugs for the Years 2019, 2024 & 2030
EUROPE
  • TABLE 23: Europe Recent Past, Current & Future Analysis for ePharmacies by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 24: Europe Historic Review for ePharmacies by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2019 through 2022 and % CAGR
  • TABLE 25: Europe 11-Year Perspective for ePharmacies by Geographic Region - Percentage Breakdown of Value Revenues for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2019, 2024 & 2030
  • TABLE 26: Europe Recent Past, Current & Future Analysis for ePharmacies by Product Type - Over-The-Counter (OTC) Drugs and Prescription Drugs - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 27: Europe Historic Review for ePharmacies by Product Type - Over-The-Counter (OTC) Drugs and Prescription Drugs Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2019 through 2022 and % CAGR
  • TABLE 28: Europe 11-Year Perspective for ePharmacies by Product Type - Percentage Breakdown of Value Revenues for Over-The-Counter (OTC) Drugs and Prescription Drugs for the Years 2019, 2024 & 2030
FRANCE
  • TABLE 29: France Recent Past, Current & Future Analysis for ePharmacies by Product Type - Over-The-Counter (OTC) Drugs and Prescription Drugs - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 30: France Historic Review for ePharmacies by Product Type - Over-The-Counter (OTC) Drugs and Prescription Drugs Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2019 through 2022 and % CAGR
  • TABLE 31: France 11-Year Perspective for ePharmacies by Product Type - Percentage Breakdown of Value Revenues for Over-The-Counter (OTC) Drugs and Prescription Drugs for the Years 2019, 2024 & 2030
GERMANY
  • TABLE 32: Germany Recent Past, Current & Future Analysis for ePharmacies by Product Type - Over-The-Counter (OTC) Drugs and Prescription Drugs - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 33: Germany Historic Review for ePharmacies by Product Type - Over-The-Counter (OTC) Drugs and Prescription Drugs Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2019 through 2022 and % CAGR
  • TABLE 34: Germany 11-Year Perspective for ePharmacies by Product Type - Percentage Breakdown of Value Revenues for Over-The-Counter (OTC) Drugs and Prescription Drugs for the Years 2019, 2024 & 2030
ITALY
  • TABLE 35: Italy Recent Past, Current & Future Analysis for ePharmacies by Product Type - Over-The-Counter (OTC) Drugs and Prescription Drugs - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 36: Italy Historic Review for ePharmacies by Product Type - Over-The-Counter (OTC) Drugs and Prescription Drugs Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2019 through 2022 and % CAGR
  • TABLE 37: Italy 11-Year Perspective for ePharmacies by Product Type - Percentage Breakdown of Value Revenues for Over-The-Counter (OTC) Drugs and Prescription Drugs for the Years 2019, 2024 & 2030
UNITED KINGDOM
  • TABLE 38: UK Recent Past, Current & Future Analysis for ePharmacies by Product Type - Over-The-Counter (OTC) Drugs and Prescription Drugs - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 39: UK Historic Review for ePharmacies by Product Type - Over-The-Counter (OTC) Drugs and Prescription Drugs Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2019 through 2022 and % CAGR
  • TABLE 40: UK 11-Year Perspective for ePharmacies by Product Type - Percentage Breakdown of Value Revenues for Over-The-Counter (OTC) Drugs and Prescription Drugs for the Years 2019, 2024 & 2030
SPAIN
  • TABLE 41: Spain Recent Past, Current & Future Analysis for ePharmacies by Product Type - Over-The-Counter (OTC) Drugs and Prescription Drugs - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 42: Spain Historic Review for ePharmacies by Product Type - Over-The-Counter (OTC) Drugs and Prescription Drugs Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2019 through 2022 and % CAGR
  • TABLE 43: Spain 11-Year Perspective for ePharmacies by Product Type - Percentage Breakdown of Value Revenues for Over-The-Counter (OTC) Drugs and Prescription Drugs for the Years 2019, 2024 & 2030
RUSSIA
  • TABLE 44: Russia Recent Past, Current & Future Analysis for ePharmacies by Product Type - Over-The-Counter (OTC) Drugs and Prescription Drugs - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 45: Russia Historic Review for ePharmacies by Product Type - Over-The-Counter (OTC) Drugs and Prescription Drugs Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2019 through 2022 and % CAGR
  • TABLE 46: Russia 11-Year Perspective for ePharmacies by Product Type - Percentage Breakdown of Value Revenues for Over-The-Counter (OTC) Drugs and Prescription Drugs for the Years 2019, 2024 & 2030
REST OF EUROPE
  • TABLE 47: Rest of Europe Recent Past, Current & Future Analysis for ePharmacies by Product Type - Over-The-Counter (OTC) Drugs and Prescription Drugs - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 48: Rest of Europe Historic Review for ePharmacies by Product Type - Over-The-Counter (OTC) Drugs and Prescription Drugs Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2019 through 2022 and % CAGR
  • TABLE 49: Rest of Europe 11-Year Perspective for ePharmacies by Product Type - Percentage Breakdown of Value Revenues for Over-The-Counter (OTC) Drugs and Prescription Drugs for the Years 2019, 2024 & 2030
ASIA-PACIFIC
  • TABLE 50: Asia-Pacific Recent Past, Current & Future Analysis for ePharmacies by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 51: Asia-Pacific Historic Review for ePharmacies by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2019 through 2022 and % CAGR
  • TABLE 52: Asia-Pacific 11-Year Perspective for ePharmacies by Geographic Region - Percentage Breakdown of Value Revenues for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2019, 2024 & 2030
  • TABLE 53: Asia-Pacific Recent Past, Current & Future Analysis for ePharmacies by Product Type - Over-The-Counter (OTC) Drugs and Prescription Drugs - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 54: Asia-Pacific Historic Review for ePharmacies by Product Type - Over-The-Counter (OTC) Drugs and Prescription Drugs Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2019 through 2022 and % CAGR
  • TABLE 55: Asia-Pacific 11-Year Perspective for ePharmacies by Product Type - Percentage Breakdown of Value Revenues for Over-The-Counter (OTC) Drugs and Prescription Drugs for the Years 2019, 2024 & 2030
AUSTRALIA
  • TABLE 56: Australia Recent Past, Current & Future Analysis for ePharmacies by Product Type - Over-The-Counter (OTC) Drugs and Prescription Drugs - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 57: Australia Historic Review for ePharmacies by Product Type - Over-The-Counter (OTC) Drugs and Prescription Drugs Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2019 through 2022 and % CAGR
  • TABLE 58: Australia 11-Year Perspective for ePharmacies by Product Type - Percentage Breakdown of Value Revenues for Over-The-Counter (OTC) Drugs and Prescription Drugs for the Years 2019, 2024 & 2030
INDIA
  • TABLE 59: India Recent Past, Current & Future Analysis for ePharmacies by Product Type - Over-The-Counter (OTC) Drugs and Prescription Drugs - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 60: India Historic Review for ePharmacies by Product Type - Over-The-Counter (OTC) Drugs and Prescription Drugs Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2019 through 2022 and % CAGR
  • TABLE 61: India 11-Year Perspective for ePharmacies by Product Type - Percentage Breakdown of Value Revenues for Over-The-Counter (OTC) Drugs and Prescription Drugs for the Years 2019, 2024 & 2030
SOUTH KOREA
  • TABLE 62: South Korea Recent Past, Current & Future Analysis for ePharmacies by Product Type - Over-The-Counter (OTC) Drugs and Prescription Drugs - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 63: South Korea Historic Review for ePharmacies by Product Type - Over-The-Counter (OTC) Drugs and Prescription Drugs Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2019 through 2022 and % CAGR
  • TABLE 64: South Korea 11-Year Perspective for ePharmacies by Product Type - Percentage Breakdown of Value Revenues for Over-The-Counter (OTC) Drugs and Prescription Drugs for the Years 2019, 2024 & 2030
REST OF ASIA-PACIFIC
  • TABLE 65: Rest of Asia-Pacific Recent Past, Current & Future Analysis for ePharmacies by Product Type - Over-The-Counter (OTC) Drugs and Prescription Drugs - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 66: Rest of Asia-Pacific Historic Review for ePharmacies by Product Type - Over-The-Counter (OTC) Drugs and Prescription Drugs Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2019 through 2022 and % CAGR
  • TABLE 67: Rest of Asia-Pacific 11-Year Perspective for ePharmacies by Product Type - Percentage Breakdown of Value Revenues for Over-The-Counter (OTC) Drugs and Prescription Drugs for the Years 2019, 2024 & 2030
LATIN AMERICA
  • TABLE 68: Latin America Recent Past, Current & Future Analysis for ePharmacies by Product Type - Over-The-Counter (OTC) Drugs and Prescription Drugs - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 69: Latin America Historic Review for ePharmacies by Product Type - Over-The-Counter (OTC) Drugs and Prescription Drugs Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2019 through 2022 and % CAGR
  • TABLE 70: Latin America 11-Year Perspective for ePharmacies by Product Type - Percentage Breakdown of Value Revenues for Over-The-Counter (OTC) Drugs and Prescription Drugs for the Years 2019, 2024 & 2030
MIDDLE EAST
  • TABLE 71: Middle East Recent Past, Current & Future Analysis for ePharmacies by Product Type - Over-The-Counter (OTC) Drugs and Prescription Drugs - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 72: Middle East Historic Review for ePharmacies by Product Type - Over-The-Counter (OTC) Drugs and Prescription Drugs Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2019 through 2022 and % CAGR
  • TABLE 73: Middle East 11-Year Perspective for ePharmacies by Product Type - Percentage Breakdown of Value Revenues for Over-The-Counter (OTC) Drugs and Prescription Drugs for the Years 2019, 2024 & 2030
AFRICA
  • TABLE 74: Africa Recent Past, Current & Future Analysis for ePharmacies by Product Type - Over-The-Counter (OTC) Drugs and Prescription Drugs - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 75: Africa Historic Review for ePharmacies by Product Type - Over-The-Counter (OTC) Drugs and Prescription Drugs Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2019 through 2022 and % CAGR
  • TABLE 76: Africa 11-Year Perspective for ePharmacies by Product Type - Percentage Breakdown of Value Revenues for Over-The-Counter (OTC) Drugs and Prescription Drugs for the Years 2019, 2024 & 2030
IV. COMPETITION

Companies Mentioned

  • 1mg Technologies Pvt. Ltd.
  • Canada Drugs
  • DocMorris NV
  • Dr Fox Pharmacy
  • eDrugstore.com
  • Express Scripts Holding Company
  • Giant Eagle, Inc.
  • InternationalDrugMart.com
  • MediSave
  • Netmeds Marketplace Limited
  • OptumRx, Inc.
  • PlanetRx
  • Rowlands Pharmacy
  • The Kroger Company
  • Walgreen Co.,
  • Wal-Mart Stores, Inc.
  • Zur Rose Group AG

Table Information